← All trials
NCT06831526
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 31, 2025
- Primary completion
- Oct 31, 2027
- Completion date
- May 31, 2029
- First posted
- Feb 18, 2025
- Last posted
- Feb 18, 2025
- Enrollment
- 12
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Washington University in St. LouisLead sponsor
- Cantex PharmaceuticalsCollaborator
- Washington University in St. LouisOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.